Syros Pharmaceuticals, Inc.
SYRS
$0.032
-$0.0067-17.31%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 58.28M | 78.96M | 108.30M | 139.53M | 112.22M |
| Total Receivables | -- | -- | -- | -- | 1.67M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.66M | 5.96M | 3.90M | 5.45M | 8.63M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 63.93M | 84.92M | 112.20M | 144.98M | 122.52M |
|
|
|||||
| Total Current Assets | 63.93M | 84.92M | 112.20M | 144.98M | 122.52M |
| Net Property, Plant & Equipment | 17.58M | 18.22M | 18.86M | 19.48M | 20.08M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.49M | 3.58M | 3.67M | 3.71M | 5.20M |
| Total Assets | 85.00M | 106.72M | 134.73M | 168.17M | 147.80M |
|
|
|||||
| Total Accounts Payable | 9.65M | 7.47M | 11.35M | 11.54M | 2.86M |
| Total Accrued Expenses | 16.16M | 14.56M | 11.88M | 16.15M | 21.49M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.58M | 2.50M | 14.08M | 8.99M | 3.91M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 139.00K |
| Total Other Current Liabilities | -- | -- | -- | -- | 139.00K |
| Total Current Liabilities | 28.39M | 24.52M | 37.30M | 36.68M | 28.39M |
|
|
|||||
| Total Current Liabilities | 28.39M | 24.52M | 37.30M | 36.68M | 28.39M |
| Long-Term Debt | 41.08M | 40.93M | 29.71M | 34.56M | 39.41M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 16.56M | 17.23M | 17.89M | 18.53M | 19.14M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 10.08M | 30.39M | 34.77M | 61.75M | 24.55M |
| Total Liabilities | 96.12M | 113.07M | 119.67M | 151.51M | 111.49M |
|
|
|||||
| Common Stock & APIC | 745.12M | 743.49M | 741.57M | 739.47M | 694.73M |
| Retained Earnings | -756.24M | -749.84M | -726.52M | -722.81M | -658.42M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -11.12M | -6.35M | 15.06M | 16.66M | 36.30M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -11.12M | -6.35M | 15.06M | 16.66M | 36.30M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -11.12M | -6.35M | 15.06M | 16.66M | 36.30M |
|
|
|||||